Overexpression of FOXM1 Is Associated With Poor Prognosis and Clinicopathologic Stage of Pancreatic Ductal Adenocarcinoma
Pancreas, 04/30/2012
Xia JT et al. – The finding indicates that forkhead box M1 (FoxM1) could be used as prognostic molecular marker and therapeutic target for pancreatic ductal adenocarcinoma (PDA).



